Caplacizumab

目录号：SY-109800

Caplacizumab (ALX-0681)为人源化抗血管性血友病因子(vWF)纳米抗体，具有抑制vWF介导的血小板粘附作用，可阻止微血栓进一步形成。该化合物在血栓性血小板减少性紫癜（TTP）研究中应用。

¥3420.00

查看详情

Erlizumab

目录号：SY-109801

Erlizumab 是一种针对整合素 beta-2 亚基 (CD18) 的人源化单克隆抗体。通过阻断白细胞表面的 CD18 与血管内皮细胞粘附分子的相互作用，该抗体能有效抑制炎症细胞的募集和浸润，从而减轻心肌缺血再灌注损伤中的组织损害。

¥769.00

查看详情

Cyclo(RGDyK)

目录号：SY-109802

Cyclo(RGDyK) is a potent and selective αVβ3 integrin inhibitor with IC50 of 20 nM.

¥1196.00

查看详情

YRGDS Fibronectin Fragment

目录号：SY-109803

This is a fibronectin fragment, an adhesion peptide that displays strong binding affinity to thrombin-stimulated platelets. It is RGD consisting of sequence.

¥460.00

查看详情

RGD Trifluoroacetate

目录号：SY-109804

RGD Trifluoroacetate is a tripeptide that binds to integrins, effectively triggering cell adhesion, targeting specific cell lines, and eliciting particular cell responses. It is the most effective and frequently employed peptide for these purposes [RGD Trifluoroacetate].

¥539.00

查看详情

EMD527040

目录号：SY-109805

EMD527040 is a powerful and highly specific αvβ6 antagonist, exhibiting notable antifibrotic properties. It is suitable for conducting research on carcinoma and liver fibrosis.

¥2002.00

查看详情